Related references
Note: Only part of the references are listed.Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
The discovery of first-in-class drugs: origins and evolution
Joerg Eder et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The PCAST Report on Pharmaceutical Innovation: Implications for the FDA
J. Woodcock
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings
Christopher A. Lipinski et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Patterns of technological innovation in biotech
Laura M. McNamee et al.
NATURE BIOTECHNOLOGY (2012)
Diagnosing the decline in pharmaceutical R&D efficiency
Jack W. Scannell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000-2009
K. I. Kaitin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
How were new medicines discovered?
David C. Swinney et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
J. A. DiMasi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Evolution of regulatory frameworks
Alasdair Breckenridge et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Lessons from 60 years of pharmaceutical innovation
Bernard Munos
NATURE REVIEWS DRUG DISCOVERY (2009)
The FDA critical path initiative and its influence on new drug development
Janet Woodcock et al.
ANNUAL REVIEW OF MEDICINE (2008)
The economics of follow-on drug research and development - Trends in entry rates and the timing of development
JA DiMasi et al.
PHARMACOECONOMICS (2004)
Central challenges facing the national clinical research enterprise
NS Sung et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
The value of improving the productivity of the drug development process - Faster times and better decisions
JA DiMasi
PHARMACOECONOMICS (2002)
Mechanism-based target identification and drug discovery in cancer research
JB Gibbs
SCIENCE (2000)
Share Paper
